DERMA SCIENCES INC's ticker is DSCI and the CUSIP is 249827502. A total of 52 filers reported holding DERMA SCIENCES INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $73,000 | +15.9% | 13,943 | +3.6% | 0.00% | – |
| Q3 2016 | $63,000 | +18.9% | 13,459 | 0.0% | 0.00% | – |
| Q2 2016 | $53,000 | +71.0% | 13,459 | +35.3% | 0.00% | – |
| Q1 2016 | $31,000 | +520.0% | 9,944 | +842.6% | 0.00% | – |
| Q4 2015 | $5,000 | 0.0% | 1,055 | -4.5% | 0.00% | – |
| Q3 2015 | $5,000 | -54.5% | 1,105 | -27.3% | 0.00% | – |
| Q2 2015 | $11,000 | +1000.0% | 1,519 | +2070.0% | 0.00% | – |
| Q1 2015 | $1,000 | -50.0% | 70 | -65.0% | 0.00% | – |
| Q4 2014 | $2,000 | -89.5% | 200 | -91.3% | 0.00% | – |
| Q3 2014 | $19,000 | +111.1% | 2,306 | +188.2% | 0.00% | – |
| Q2 2014 | $9,000 | +800.0% | 800 | +1438.5% | 0.00% | – |
| Q4 2013 | $1,000 | -98.8% | 52 | -99.2% | 0.00% | – |
| Q3 2013 | $83,000 | +130.6% | 6,698 | +151.3% | 0.00% | – |
| Q2 2013 | $36,000 | – | 2,665 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 507,799 | $1,574,000 | 1.86% |
| Krensavage Asset Management, LLC | 906,046 | $2,809,000 | 1.01% |
| DAFNA Capital Management LLC | 353,718 | $1,097,000 | 0.95% |
| Broadfin Capital, LLC | 2,562,104 | $7,943,000 | 0.77% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 124,549 | $386,000 | 0.18% |
| Senvest Management, LLC | 489,807 | $1,518,000 | 0.13% |
| Baker Brothers Advisors | 3,752,390 | $11,632,000 | 0.12% |
| Perceptive Advisors | 432,884 | $1,341,000 | 0.12% |
| Granahan Investment Management | 1,028,460 | $3,188,000 | 0.12% |
| Alambic Investment Management, L.P. | 49,035 | $152,000 | 0.05% |